Page results
-
This page provides information about an interventional procedure called an Epidural Fibrin Patch. It is intended for use by patients (or their family or carers), who have been referred to the NHNN.
-
The fertility laboratory provides three main services. Semen analysis to test fertility, storage of semen samples and processing of semen samples for IUI treatments.
-
Perinatal Mental Health Service in Partnership with North London Partners Specialist Perinatal Mental Health Service
-
Antenatal care and screening is an essential part of maternity care for all women. We provide state-of-the-art ultrasound screening, specialist obstetric and midwifery clinics.
-
A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.
-
As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.
-
Find & Treat's new prototype Eco-Tricycle will visit parks, hostels, soup kitchens, be able to arrive under bridges or other street outreach locations to screen homeless patients for infectious diseases and more.
-
The Getting Ready for Transition (GReaT) Group is an interactive workshop for young people with Type I Diabetes, who will be transitioning to secondary school in September, and their parents.
-
UCLH today marks International Clinical Trials Day, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
-
This information is for patients who are doing a breath test at home. It includes the risks, and explains how to prepare, complete and return the test, as well as what to expect after the test.
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment